Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: PPD DEVELOPMENT LP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-29 to 2025-08-12
Current total value of award: $2791811
Description: EPCTU - TO IMPLEMENT PHASE 0 TO PHASE II CLINICAL TRIALS, INCLUDING PROOF-OF-CONCEPT STUDIES IN HEALTHY AND DISEASED HUMAN POPULATIONS, DOMESTICALLY AND INTERNATIONALLY, AIDED BY BIOANALYSIS WHEN NECESSARY. PHASE III STUDIES MAY BE CONDUCTED OCCASI